CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population.

Tahara T, Shibata T, Hirata I, Nakano H, Arisawa T

Open source

DOI
10.1007/s10620-009-0793-5
Published
2009 Jul
Container
Digestive diseases and sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10620-009-0793-5,
  title = {CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population.},
  author = {Tahara T and Shibata T and Hirata I and Nakano H and Arisawa T},
  year = {2009},
  journal = {Digestive diseases and sciences},
  doi = {10.1007/s10620-009-0793-5},
  url = {https://doi.org/10.1007/s10620-009-0793-5}
}

RIS

TY  - JOUR
TI  - CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population.
AU  - Tahara T
AU  - Shibata T
AU  - Hirata I
AU  - Nakano H
AU  - Arisawa T
PY  - 2009
JO  - Digestive diseases and sciences
DO  - 10.1007/s10620-009-0793-5
UR  - https://doi.org/10.1007/s10620-009-0793-5
ER  - 

APA

T, T., T, S., I, H., H, N., & T, A. (2009). CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population.. Digestive diseases and sciences. https://doi.org/10.1007/s10620-009-0793-5

Source records